Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs

East Midlands
6 March 2015 10:20

West Midlands, South West and Wales.
6 March 2015 10:13

Wiltshire, Swindon and Bath
6 March 2015 09:23

Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
+44 1494 818 049

I feel compelled to thank you for the service that you provided me with over the last two years. I found everyone that I dealt with to be very professional and efficient but always appreciated the hum...
Neil, 2011

Innovative new stem cell research into Alzheimer's to commence

22 November 2011 00:00 in Scientific Developments/Breakthroughs

The University of Bristol has received funding to commence an innovative new study that will use groundbreaking stem cell technology to reveal new insight into Alzheimer's disease.

A grant of 164,000 pounds has been awarded by the charity organisation Brace to conduct the study, which will use stem cell advances to convert skin biopsy samples into nerve cells, similar to those found in a part of the brain known as the nucleus basalis.

These cells will be taken from Alzheimer's patients and compared to control samples in order to find out how they differ, allowing researchers to see what factors can affect the development of the disease.

It is thought that these methods can provide a much more accurate modelling of Alzheimer's on a cellular level than was previously possible, thus revealing vital insights into how the condition functions.

Dr Maeve Caldwell, senior research fellow for the university's school of clinical sciences, said the study "should enable us ... to test a range of hypotheses concerning the earliest abnormalities in Alzheimer's, the environmental influences on their development, and the extent to which they can be prevented or reversed".

This comes after University of Bristol spin-out company Azellon Cell Therapeutics received funding to trial a new stem cell bandage earlier this month.ADNFCR-8000103-ID-801217972-ADNFCR

Other news stories from 22/11/2011

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd